These findings suggest that hypertension plays a critical role in the development of advanced glomerular lesions in diabetic eNOS −/− mice and that eNOS deficiency induces aldosterone breakthrough, reducing the efficacy of RAS blockades for DN. The gene discussed is NOS3; the disease is Hypertension.